Alpha Teknova (NASDAQ:TKNO) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Alpha Teknova (NASDAQ:TKNO) to a hold rating in a research report report published on Thursday,Zacks.com reports.

Other equities research analysts have also issued research reports about the stock. Roth Capital began coverage on shares of Alpha Teknova in a report on Wednesday. They issued a “buy” rating and a $7.00 price target on the stock. Wall Street Zen raised shares of Alpha Teknova from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alpha Teknova in a research report on Friday, July 17th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Alpha Teknova currently has an average rating of “Hold” and an average target price of $7.00.

Alpha Teknova Trading Down 1.1%

Alpha Teknova stock opened at $6.46 on Thursday. The business has a 50 day moving average price of $5.23 and a two-hundred day moving average price of $3.75. The company has a quick ratio of 3.60, a current ratio of 4.59 and a debt-to-equity ratio of 0.20. Alpha Teknova has a 12 month low of $1.91 and a 12 month high of $6.68. The stock has a market cap of $346.32 million, a price-to-earnings ratio of -20.84 and a beta of 0.64.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. The business had revenue of $12.19 million for the quarter, compared to analysts’ expectations of $10.95 million. Alpha Teknova had a negative return on equity of 24.38% and a negative net margin of 38.37%. As a group, equities analysts forecast that Alpha Teknova will post -0.32 EPS for the current year.

Institutional Trading of Alpha Teknova

A number of large investors have recently bought and sold shares of TKNO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Alpha Teknova in the 2nd quarter valued at $29,000. JPMorgan Chase & Co. increased its position in shares of Alpha Teknova by 123.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after purchasing an additional 4,504 shares in the last quarter. Larson Financial Group LLC lifted its holdings in Alpha Teknova by 58.5% during the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after purchasing an additional 3,464 shares during the last quarter. ProShare Advisors LLC bought a new position in Alpha Teknova during the 4th quarter valued at about $38,000. Finally, Deutsche Bank AG acquired a new position in Alpha Teknova in the second quarter valued at about $62,000. 13.81% of the stock is currently owned by institutional investors.

Alpha Teknova Company Profile

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.